Bilateral macular ischemia and severe visual loss following trastuzumab therapy

Acta Oncologica

Volumn 50, Issue 3, 2011, Pages 477-478

  Saleh, Maher ^a   Bourcier, Tristan ^a   Noel, Georges ^b   Speeg Schatz, Claude ^a   Gaucher, David ^a  

^a HÔPITAL CIVIL   (France)

^b CENTRE PAUL STRAUSS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; TRASTUZUMAB;

ADULT; ARTICLE; BRAIN CANCER; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CAPILLARY LEAK SYNDROME; CASE REPORT; CENTRAL MACULAR THICKNESS; CHEMORADIOTHERAPY; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG METASTASIS; MULTIMODALITY CANCER THERAPY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REPEAT PROCEDURE; RETINA DETACHMENT; RETINA EXUDATE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA ISCHEMIA; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RETINA MACULA HEMORRHAGE; RETINA MACULA ISCHEMIA; RETINA MACULOPATHY; SIDE EFFECT; VISION; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT; VISUAL SYSTEM PARAMETERS;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARCINOMA; EYE DISEASES; FEMALE; HUMANS; ISCHEMIA; MACULAR DEGENERATION; MIDDLE AGED; NEOPLASM METASTASIS; SEVERITY OF ILLNESS INDEX; VISION, LOW;

EID: 79952640753     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.555781     Document Type: Article

References (9)

1. Guarneri V, Barbieri E, Dieci MV, Piacentini F, Conte P. Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer. Cancer Treat Rev 2010;36 (Suppl 3):S62-6.
2. De Vita F, Giuliani F, Silvestris N, Catalano G, Ciardiello F, Orditura M. Human epidermal growth factor receptor 2 (HER2) in gastric cancer: A new therapeutic target. Cancer Treat Rev 2010;36(Suppl 3):S11-5.
3. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation retinopathy after external-beam irradiation: Analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:765-73. (Pubitemid 24355923)
4. Horgan N, Shields CL, Mashayekhi A, Shields JA. Classification and treatment of radiation maculopathy. Curr Opin Ophthalmol 2010;21:233-8.
5. Telander DG, Sarraf D. Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol 2007;22:151-3. (Pubitemid 47346970)
6. Izumi Y, Xu L, di Tomaso E, Fukumura D, Jain RK. Tumour biology: Herceptin acts as an anti-angiogenic cocktail. Nature 2002;416(6878):279-80. (Pubitemid 34260234)
7. Sabet-Peyman EJ, Heussen FM, Thorne JE, Casparis H, Patel SJ, Do DV. Progression of macular ischemia following intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging 2009;40:316-8.
8. Witzel ID, Muller V, Harps E, Janicke F, Dewit M. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 2008;19:191-2.
9. eHealthme-real world drug outcomes (internet database). Herceptin reports. Available on http://www.ehealthme.com/.